MedTrace Logo

STAMP+CBT mHealth for Cancer Pain

NCT05403801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-01-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.

Conditions

  • Active Cancer
  • Active Cancer Treatment
  • Advanced Cancer
  • Palliative Care
  • Chronic Pain Due to Cancer

Interventions

BEHAVIORAL

STAMP+CBT application

Use the STAMP+CBT mobile app for 4 weeks (intervention period, 4 weeks for content introduction, extended 2 weeks for review of content if patient's request this

Sponsors & Collaborators

Principal Investigators

  • Desiree Azizoddin, PsyD · Dana-Farber Cancer Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-06-08
Completion
2023-06-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05403801 on ClinicalTrials.gov